Finance

Lists
249420:KRX
Il Dong Pharmaceutical Co Ltd
13 750,00 KRW
+0,88%
(+120,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 249420...
Open
13 400 KRW
High
13 750 KRW
Low
13 250 KRW
Mkt. cap
435,03 მლრ.
Avg. vol.
359,73 ათ.
Volume
77,97 ათ.
Dividend
1,45%
Quarterly dividend
50 KRW
Ex-dividend date
30 მარ. 2026
P/E ratio
9,72
52-wk high
45 050 KRW
52-wk low
11 250 KRW
EPS
1 415 KRW
Shares outstanding
31,64 მლნ.
No. of employees
1 ათ.
Open
13 400 KRW
High
13 750 KRW
Low
13 250 KRW
Mkt. cap
435,03 მლრ.
Avg. vol.
359,73 ათ.
Volume
77,97 ათ.
Dividend
1,45%
Quarterly dividend
50 KRW
Ex-dividend date
30 მარ. 2026
P/E ratio
9,72
52-wk high
45 050 KRW
52-wk low
11 250 KRW
EPS
1 415 KRW
Shares outstanding
31,64 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Il Dong Pharmaceutical Co Ltd
CEOვუნგ სოფ იუნ
Employees1,05 ათ.
Founded1941
Headquarters-
SectorPharmaceutical industry
Websiteildong.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
145,46 მლრ.
147,02 მლრ.
142,00 მლრ.
147,86 მლრ.
Cost of goods sold
86,98 მლრდ.
90,12 მლრდ.
83,46 მლრდ.
91,24 მლრდ.
Cost of revenue
86,98 მლრდ.
90,12 მლრდ.
83,46 მლრდ.
91,24 მლრდ.
Research and development expenses
9,38 მლრდ.
9,15 მლრდ.
9,06 მლრდ.
10,55 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40,49 მლრდ.
38,46 მლრდ.
38,99 მლრდ.
42,93 მლრდ.
Operating expense
51,72 მლრდ.
51,15 მლრდ.
49,13 მლრდ.
53,00 მლრდ.
Total operating expenses
138,70 მლრ.
141,27 მლრ.
132,59 მლრ.
144,24 მლრ.
Operating income
6,76 მლრდ.
5,75 მლრდ.
9,41 მლრდ.
3,62 მლრდ.
Other non operating income
16,98 მლრდ.
2,25 მლრდ.
493,34 მლნ.
313,42 მლნ.
EBT including unusual items
28,30 მლრდ.
6,09 მლრდ.
9,20 მლრდ.
3,46 მლრდ.
EBT excluding unusual items
21,28 მლრდ.
6,09 მლრდ.
8,16 მლრდ.
2,74 მლრდ.
Income tax expense
6,81 მლრდ.
489,84 მლნ.
1,82 მლრდ.
-1,64 მლრდ.
Effective tax rate
24,07%
8,04%
19,79%
-47,36%
Other operating expenses
446,84 მლნ.
249,24 მლნ.
261,46 მლნ.
207,71 მლნ.
Net income
22,41 მლრდ.
7,24 მლრდ.
8,27 მლრდ.
5,70 მლრდ.
Net profit margin
15,40%
4,92%
5,82%
3,85%
Earnings per share
-
-
-
-
Interest and investment income
172,88 მლნ.
102,81 მლნ.
109,44 მლნ.
231,08 მლნ.
Interest expense
-2,77 მლრდ.
-1,93 მლრდ.
-1,82 მლრდ.
-1,81 მლრდ.
Net interest expenses
-2,60 მლრდ.
-1,82 მლრდ.
-1,71 მლრდ.
-1,58 მლრდ.
Depreciation and amortization charges
1,25 მლრდ.
1,20 მლრდ.
1,07 მლრდ.
1,08 მლრდ.
EBITDA
12,46 მლრდ.
11,08 მლრდ.
14,91 მლრდ.
9,15 მლრდ.
Gain or loss from assets sale
140,84 მლნ.
3,66 მლნ.
10,12 მლნ.
753,47 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები